Raboral V-RG Ēsma lapsām
Raboral V-RG Ēsma lapsām
Authorised
- Vaccinia virus, expressing glycoprotein gene of rabies virus, Live
Product identification
Medicine name:
Raboral V-RG Ēsma lapsām
Active substance:
- Vaccinia virus, expressing glycoprotein gene of rabies virus, Live
Target species:
-
Fox
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Vaccinia virus, expressing glycoprotein gene of rabies virus, Live100000000.00/50% cell culture infectious dose1.00unit(s)
Pharmaceutical form:
-
Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07BD
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/03/1613
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 22/03/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 22/03/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 22/03/2024